Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Details 1)

v3.20.1
Stockholders' Equity (Details 1) - $ / shares
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Stockholders' Equity Note [Abstract]    
Stock options outstanding, beginning 302,772 0
Stock options acquired in merger 0 133,711
Stock options granted 99,072 214,239
Stock options forfeited (21,448) (45,178)
Stock options outstanding, ending 380,396 302,772
Weighted average exercise price outstanding, beginning $ 18.30 $ 0.00
Weighted average exercise price acquired in merger .00 36.42
Weighted average exercise price granted 2.32 5.58
Weighted average exercise price forfeited 13.09 11.64
Weighted average exercise price outstanding, ending $ 14.43 $ 18.30
Weighted average remaining contractual life, beginning 7 years 2 months 12 days  
Weighted average remaining contractual life acquired in merger   3 years 10 months 17 days
Weighted average remaining contractual life granted 9 years 1 month 2 days 9 years 8 months 19 days
Weighted average remaining contractual life, ending 6 years 10 months 2 days 7 years 2 months 12 days